Breaking News, Financial News

Baxter International

Global injectable sales up 14% for the year.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Baxter 3Q10 3Q10 Revenues: $3.2 billion (+3%) 3Q10 Earnings: $595 million (+12%) YTD Revenues: $9.3 billion (+3%) YTD Earnings: $1.1 billion (-31%) Comments: The BioScience unit posted flat sales of $1.4 billion in the quarter, while Medication Delivery sales were up 5% to $1.2 billion. Global injectable sales rose 8% to $469 million in the quarter, and 14% to $1.4 billion for YTD....

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters